Skip to main content
Log in

Synthesis of a fluorescent analogue of methotrexate lipophilic prodrug

  • Letter to the Editor
  • Published:
Russian Journal of Bioorganic Chemistry Aims and scope Submit manuscript

Abstract

A fluorescent analogue of the lipophilic prodrug of antitumor agent methotrexate has been synthesized. The conjugate consists of a residue of rac-1-[13-(Me4-BODIPY-8)tridecanoyl]-2-oleoylglycerol connected to methotrexate by an ester bond via β-Ala-N-carbonylmethylene linker (Me4-BODIPY-8 stands for 4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl). The probe is designed for incorporation in the membrane of the liposomal vehicle to study a mechanism of interaction with tumor cells and intracellular traffic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

MTX:

methotrexate

MTX-DG:

rac-1,2-dioleoylglyceride conjugate of MTX

DHFR:

dihydrofolate reductase

RFC:

reduced folate carrier

Me4-BODIPY-8, or BDP:

4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl

Gro:

glycerol

Ole:

oleoyl (9Z-heptadecenyl-17-carbonyl)

TEA:

triethylamine

References

  1. Abolmaali, S.S., Tamaddon, A.M., and Dinarvand, R., Cancer Chemother. Pharmacol., 2013, vol. 71, pp. 1115–1130.

    Article  CAS  PubMed  Google Scholar 

  2. Purcell, W.T. and Ettinger, D.S., Curr. Oncol. Rep., 2003, vol. 5, pp. 114–125.

    Article  PubMed  Google Scholar 

  3. McGuire, J.J., Curr. Pharm. Design, 2003, vol. 9, pp. 2593–2613.

    Article  CAS  Google Scholar 

  4. Khan, Z.A., Tripathi, R., and Mishra, B., Expert Opin. Drug Deliv., 2012, vol. 9, pp. 151–169.

    Article  CAS  PubMed  Google Scholar 

  5. Kaminskas, L.M., Kelly, B.D., McLeod, V.M., Sberna, G., Boyd, B.J., Owen, D.J., and Porter, C.J., Mol. Pharm., 2011, vol. 8, pp. 338–349.

    Article  CAS  PubMed  Google Scholar 

  6. Homma, A., Sato, H., Tamura, T., Okamachi, A., Emura, T., Ishizawa, T., Kato, T., Matsuura, T., Sato, S., Higuchi, Y., Watanabe, T., Kitamura, H., Asanuma, K., Yamazaki, T., Ikemi, M., Kitagawa, H., Morikawa, T., Ikeya, H., Maeda, K., Takahashi, K., Nohmi, K., Izutani, N., Kanda, M., and Suzuki, R., Bioorgan. Med. Chem., 2010, vol. 18, pp. 1062–1075.

    Article  CAS  Google Scholar 

  7. Srisuka, P., Thongnopnuab, P., Raktanonchaic, U., and Kanokpanontd, S., Int. J. Pharm., 2012, vol. 427, pp. 426–434.

    Article  Google Scholar 

  8. Prabhu, P., Shetty, R., Koland, M., Vijayanarayana, K., Vijayalakshmi, K.K., Nairy, M.H., and Nisha, G.S., Int. J. Nanomedicine, 2012, vol. 7, pp. 177–186.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Maeda, H., Sawa, T., and Konno, T., J. Control. Release, 2001, vol. 74, pp. 47–61.

    Article  CAS  PubMed  Google Scholar 

  10. Drummond, D.C., Hong, K., Kirpotin, D.B., and Park, J.W., Drug Resist. Updates, 2003, vol. 6, pp. 271–279.

    Article  Google Scholar 

  11. Vodovozova, E.L., Evdokimov, D.V., and Molotkovsky, Jul.G., Rus. J. Bioorgan. Chem., 2004, vol. 30, pp. 599–601.

    Article  CAS  Google Scholar 

  12. Vodovozova, E.L., Gaenko, G.P., Bobrikova, E.S., Pazynina, G.V., and Molotkovskii, Yul.G., Khim.Farm. Zh., 2007, vol. 41, pp. 10–14.

    Google Scholar 

  13. Kuznetsova, N., Kandyba, A., Vostrov, I., Kadykov, V., Gaenko, G., Molotkovsky, J., and Vodovozova, E., J. Drug Deliv. Sci. Techn., 2009, vol. 19, pp. 51–59.

    CAS  Google Scholar 

  14. Liederer, B.M. and Borchardt, R.T., J. Pharm. Sci., 2006, vol. 95, pp. 1177–1195.

    Article  CAS  PubMed  Google Scholar 

  15. Rosowsky, A., Forsch, R.A., Yu, C.-S., Lazarus, H., and Beardsley, G.P., J. Med. Chem., 1984, vol. 27, pp. 605–609.

    Article  CAS  PubMed  Google Scholar 

  16. Pignatello, R., Spampinato, G., Sorrenti, V., Di Giacomo, C., Vicari, L., McGuire, J.J., Russell, C.A., Puglisi, G., and Toth, I., Eur. J. Pharm. Sci., 2000, vol. 10, pp. 237–245.

    Article  CAS  PubMed  Google Scholar 

  17. Vodovozova, E.L., Kuznetsova, N.R., Gaenko, G.P., and Molotkovsky, Jul.G., Rus. J. Bioorgan. Chem., 2007, vol. 33, pp. 436–438.

    Article  CAS  Google Scholar 

  18. Kuznetsova, N.R., Sevrin, C., Lespineux, D., Bovin, N.V., Vodovozova, E.L., Meszaros, T., Szebeni, J., and Grandfils, C., J. Control. Release, 2012, vol. 160, pp. 394–400.

    Article  CAS  PubMed  Google Scholar 

  19. Boldyrev, I.A. and Molotkovsky, Jul.G., Rus. J. Bioorgan. Chem., 2006, vol. 32, pp. 78–83.

    Article  CAS  Google Scholar 

  20. Vodovozova, E.L. and Molotkovsky, J.G., Tetrahedron Lett., 1994, vol. 35, pp. 1933–1936; corrigendum, Vodovozova, E.L. and Molotkovsky, J.G., Tetrahedron Lett., 1994, vol. 35, p. 8062.

    Article  CAS  Google Scholar 

  21. Cheung, H.T.A., Boadle, D.K., and Tran, T.Q., Heterocycles, 1989, vol. 28, pp. 751–758.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. L. Vodovozova.

Additional information

Original Russian Text © Yu.V. Vlasenko, A.S. Alekseeva, E.L. Vodovozova, 2014, published in Bioorganicheskaya Khimiya, 2014, Vol. 40, No. 1, pp. 125–128.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vlasenko, Y.V., Alekseeva, A.S. & Vodovozova, E.L. Synthesis of a fluorescent analogue of methotrexate lipophilic prodrug. Russ J Bioorg Chem 40, 114–117 (2014). https://doi.org/10.1134/S1068162014010129

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1068162014010129

Keywords

Navigation